Seasonal variation in the occurrence of several classes of cancer has been observed in the past. However, evidence for such trends in adult central nervous system tumors is scant.
INTRODUCTION
Understanding seasonal variations in disease occurrence can provide insights into pathogenesis which may have diagnostic and therapeutic implications. The identification of seasonal trends for a number of cancers has led to the investigation of potential causative environmental factors. Examples include prostate [1] , thyroid [2] and skin cancers [3] , which have been linked to the effect of varying daylight and UV radiation on vitamin D synthesis. Exposure to infectious agents has been implicated in the seasonality of cervical cancer [4] , lymphomas [5] and frog adenocarcinomas [6, 7] . Similar correlations have been proposed for breast cancer with pineal biorhythms and expression of progesterone receptor [8] . However, no definitive consensus for seasonal patterns in breast cancer exists [9, 10] .
Associations between season of birth and occurrence of brain tumors have been reported [11, 12] , pointing to possible pre-or postnatal effects. To our knowledge, the only reported observation of seasonal variation in adult malignant brain tumors was made from the Tumorzentrum Regensburg database in southeastern Germany [13] . The investigators reported circannual periodicity for glioblastomas in women but not in men.
The current study presents further evidence for periodicity in the occurrence of glioblastomas and carcinomas metastatic to the central nervous system (CNS) over a sevenyear period in Toronto, Canada. In addition, histological analysis of glioblastomas suggests the presence of seasonally-variable inflammatory and vascular events.
PATIENTS AND METHODS
Cases were selected from a neuropathologic database created from print and electronic archives at Toronto's University Health Network spanning 1971 to the present and containing more than 31,000 specimens [14] . A seven-year period was chosen for the current study (July 2001 to June 2008). Two groups of tumors were selected for review: glioblastomas and metastatic carcinomas. Recurrent or previously treated cases were excluded. Anatomic locations were restricted to the cerebrum and cerebellum. Tumors were grouped by month of surgery, and frequency was calculated relative to the total number of neurosurgical cases in that month. Gender-based trends were also assessed. All queries of the database conformed to the University Health Network Research Ethics Board guidelines. In particular, no information was extracted from the repository that could lead to the recognition of patient identities.
To investigate the biological basis of seasonal trends in glioblastomas, histopathology was compared between a peak (March) and a trough (November) month of frequency. Hematoxylin and eosin-stained sections of these tumors were reviewed by two neuropathologists (S.E.C. and T.R.K.) blinded to the month of surgery. Six major microscopic features (necrosis, pseudopalisades, microvascular proliferation, thrombosis, perivascular lymphocytic inflammation and hemosiderin deposition) were scored semiquantitatively as absent (0), minimal (1) or extensive (2).
Statistical analyses for seasonality studies are classically performed using the Roger test [15] . An alternative method increases power by utilizing the premises of the hypothesis being examined [16] . It assumes two seasons to be proportionally constant, the third to have peaked, and the fourth to be below average. For the seasonality analyses in this study, we used a modification of Nam's method (see Supplement). The major peaks in each trend were tested for significance against other monthly values, which were assumed to have minor variation relative to the yearly average. Statistical significance tests for histological analyses were performed using a two-sample, one-tailed Student's t-test assuming equal variance, with P-values less than 0.05 considered significant.
RESULTS
Among the 6,154 neurosurgical cases in the selected period, 505 glioblastomas (316 males, 189 females, mean age = 58.6 ± 14.3) and 386 metastatic carcinomas (167 males, 219 females, mean age = 59.6 ± 11.8) were found. Gender distribution among all cases was 48.3% female and 51.7% male, with no particular gender being overrepresented in a given month. The frequency trend for glioblastomas showed highly significant peaks in March, June, September and December (Z = 3.329, P = 0.0004), and metastatic carcinomas demonstrated peaks in January, April and August (Z = 2.697, P = 0.0035) ( Figure 1A) . Therefore, the peak/trough patterns of the two tumor groups closely resembled each other.
Furthermore, no significant gender differences were observed (Figures 1B, C) .
Histologic evaluation of all glioblastoma cases from a peak (n = 33) and trough (n = 32) month demonstrated a significant increase in the amount of perivascular lymphocytic inflammation (P = 0.048) in the trough month (Figure 2 ). There were no significant differences in other histologic features, namely thrombosis (P = 0.167), hemosiderin (P = 0.175), pseudopalisades (P = 0.208), necrosis (P = 0.233) and vascular proliferation (P = 0.336).
DISCUSSION
We have demonstrated significant seasonal variation in the presentation of both glioblastoma and CNS-metastatic carcinoma. The degree of malignancy and rapid growth of these lesions usually mandates surgery within a short time after first clinical symptoms, ensuring a close correlation between initial presentation and the true occurrence of the disease. Moreover, the use of the frequency of diagnosis as a fraction of total neurosurgical cases rather than the number of diagnoses in this study eliminated potential effects of external variables, such as the number of neurosurgeons on duty or level of experience of the surgical staff in any given month. In addition, the months chosen for histological analysis did not constitute typical vacation times or periods of unusual surgical load.
The trend found for glioblastoma cases in our series is similar to that reported by Koch and colleagues (2005) , who demonstrated significant peaks in March and September in female patients. Unlike that study, however, no gender differences were found in our series. The number of glioblastomas analyzed in the mentioned report (501 cases between 1992 and 2003) was comparable to the study presented here. The male : female ratios (approximately 1.5 : 1) for glioblastomas were also consistent with reported values [17] .
Alternative statistical methods for seasonality analyses based on the date of clinical diagnosis and utilizing the von Mises distribution and angular regression methods have been suggested [18] . However, due to the existence of technical difficulties with these approaches as detailed by Gao et al. (2006) , and the configuration of our database, we decided to group our data on a monthly basis and develop an extension to a model suggested earlier (see Supplement). Frequencies of glioblastoma diagnoses therefore closely resemble the trend for metastatic carcinomas. Gender-specific analysis demonstrates close resemblance of the combined graphs, notwithstanding male bias in glioblastoma cases (B) and female bias in the combined metastatic carcinoma cases (C). 
Frequency (per total monthly cases)
Metastatic Carcinoma Glioblastoma and Gliosarcoma 
